Clinical Efficacy Study of Tolvaptan on Patients with Autosomal Dominant Polycystic Kidney Disease
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Tolvaptan (Primary)
- Indications Autosomal dominant polycystic kidney disease
- Focus Therapeutic Use
- 09 Nov 2016 New trial record
- 02 Nov 2016 Status changed from recruiting to completed.